FDA phasing out animal testing in preclinical safety studies
AVMA News
JUNE 4, 2025
The Food and Drug Administration has announced its plan to phase out its animal testing requirement for preclinical safety studies in the development of monoclonal antibody therapies and other drugs.
Let's personalize your content